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Abstract
Background: The length of stay (LOS) in intensive care units (ICUs) has been used as a good indicator not only for
resource consumption but also for health outcomes of patients. However, data regarding pediatric LOS in Japanese
ICUs are limited. The primary aim of this study was to characterize the Japanese pediatric ICU patients based on
their LOS. Second, we aimed to develop a simple scoring system to predict long-stay pediatric ICU patients on
admission.
Methods: We performed a retrospective cohort study using consecutive pediatric data (aged < 16 years) registered
in the Japanese Registry of Pediatric Acute Care (JaRPAC) from October 2013 to September 2016, which consisted
of descriptive and diagnostic information. The factors for long-stay patients (LSPs; LOS > 14 days) were identified
using multiple regression analysis, and subsequently, a simple predictive scoring system was developed based on
the results. The validity of the score was prospectively tested using data from the JaRPAC registration from October
2016 to September 2017.
Results: Overall, 4107 patients were included. Although LSPs were few (8.0% [n = 330]), they consumed 38.0% of
ICU bed days (9750 for LSPs versus 25,659 overall). Mortality was seven times higher in LSPs than in short-stay
patients (9.1% versus 1.3%). An 11-variable simple predictive scoring system was constructed, including Pediatric
Index of Mortality 2 ≥ 1 (2 points), liver dysfunction (non-post operation) (2 points), post-cardiopulmonary
resuscitation (1 point), circulatory disorder (1 point), post-operative management of liver transplantation (1 point),
encephalitis/encephalopathy (1 point), myocarditis/cardiomyopathy (1 point), congenital heart disease (non-post
operation) (1 point), lung tissue disease (1 point), Pediatric Cerebral Performance Category scores ≥ 2 (1 point), and
age < 2 years (1 point). A score of ≥ 3 points yielded an area under the receiver operating characteristic curve (AUC)
of 0.79, sensitivity of 87.0%, and specificity of 59.4% in the original dataset. Reproducibility was confirmed with the
internal validation dataset (AUC 0.80, sensitivity 92.6%, and specificity 60.2%).
Conclusions: Pediatric LSPs possess a significant presence in Japanese ICUs with high rates of bed utilization and
mortality. The newly developed predictive scoring system may identify pediatric LSPs on admission.
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Background
Long-stay patients (LSPs) in intensive care units
(ICUs) are generally accepted as being susceptible to
higher mortality than short-stay patients (SSPs) [1]. In
addition, they consume a higher amount of medical
costs, resources, and ICU capacity [2]. Since the
1980s, when pediatric LSPs in ICUs first got attention
in research [3], the number of pediatric LSPs in ICUs
has been increasing, with the development of life-sup-
porting skills and technologies such as the availability
of the pediatric advanced life support course or extra-
corporeal membrane oxygenation therapy [4]. Mul-
tiple studies reported that they are responsible for
more than one third of ICU bed days although the
proportion of LSPs among the entire admitted popu-
lation is smaller than 10% [3, 5–7]. It is often the
case for pediatric LSPs that their functional outcomes
are unfavorable (moderate or severe disabilities, and
death) [8]. Although these basic data are essential for
discussion to improve the current ICU practices for
pediatric patients, Japan has little data about pediatric
LSPs in the ICU.
Predicting LSPs in ICUs on admission has been another
interest of research for decades [6, 9–12]. Appropriate
prediction might provide practical assistance for proactive
patient management in ICUs [11]. Health care teams
could be dedicated to communicate and purvey sufficient
information to families and clinicians could deliberately
provide preventive care against different complications.
ICU staff could systematically schedule bed use and med-
ical resources. Experienced ICU staff might be able to pre-
dict pediatric LSPs on admission; however, this would be
unreliable. In fact, clinicians could predict LSPs less cor-
rectly than SSPs in adult ICU settings [13]. There have
been several studies in the USA that attempted to develop
predictive models for the length of stay (LOS) of pediatric
patients in the ICU [5, 6]. However, it is easily assumed
that these foreign models have limited applicability to
pediatric populations in Japanese ICUs because of the
wide differences in common diseases among children and
health care systems [14, 15]. Moreover, the discussion re-
garding LSP prediction for pediatric patients in the ICU is
still poor in Japanese ICUs.
The paucity of data prompted us to survey the
pediatric LSP population in Japanese ICUs and to cre-
ate a useful system to identify them in the early ICU
course, using consecutive pediatric data (< 16 years
old) registered in the Japanese Registry of Pediatric
Acute Care (JaRPAC).
Methods
JaRPAC overview
JaRPAC is an observational, multicenter, prospective
database that contains data on consecutive pediatric
patients admitted to ICUs in Japan. The registry was
started on October 1, 2013. The study is mainly led
by the pediatric committee of the Japanese Society for
Emergency Medicine and the study website can be
reached at jarpac.org. The JaRPAC registry includes
information on admitted patients to ICU or those
who died in the emergency room. The subjects in
children’s hospitals are all registered regardless of
their age, while those in other hospitals are registered
if their age is less than 16 years. Otherwise, no exclu-
sion criteria are applied to the registry. Using applica-
tion software designated for this database, patients’
data are collected with 23 variables at admission and
27 variables at discharge from ICU, including data re-
garding pre-hospital management, the predictive death
rate, demographics, treatments, and outcomes. The
software equips automated logic checks to avoid
miss-hit or data deficiencies. The registry is securely
held at the National Center of Child Health and De-
velopment (NCCHD) and anonymized data are pro-
vided to the principal investigator on request with a
specific study protocol that was approved by the JaR-
PAC steering committee. The study results are avail-
able to the public in the form of annual reports,
conference abstracts, and peer-reviewed publications.
Patient data
We obtained the following 3 year JaRPAC data of
consecutive patients aged less than 16 years who were
admitted to ICU from October 2013 to September
2016 to survey the characteristics of pediatric LSPs in
ICUs (analysis dataset): sex, age in month, dates of
admission and discharge from the ICU, reasons for
ICU admission, diagnosis at discharge, disease
category, elective/emergency admission status, cardio-
pulmonary resuscitation (CPR) before admission or
during the ICU stay, Pediatric Index of Mortality 2
(PIM2) [16], chromosome abnormalities, discharge
disposition, and Pediatric Cerebral Performance Cat-
egory (PCPC) score [17] before admission and at dis-
charge from the ICU. The Injury Severity Score (ISS)
[18] was extracted for all patients with injuries. JaR-
PAC codes the reason for admission into seven cat-
egories: postoperative management, post CPR,
respiratory distress, circulatory disorder, neurological
disorders, monitoring/assessment, and others. Allow-
able values for discharge disposition in JaRPAC are
defined within five categories: general ward, back
transferred to the original hospital, transferred to an-
other hospital, home, and expired. Furthermore, JaR-
PAC categorizes diseases in a three-step manner; an
additional table file shows this in more details (see
Additional file 1). PIM2 and PCPC scores are the
fundamental tools used worldwide for the evaluation
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of pediatric patients in the ICUs. Briefly, PIM2, the
calculation system for predicting mortality rates for
pediatric patients, uses 10 variables. The PCPC score
is a tool for quantifying short-term cognitive impair-
ments in pediatric patients; it has a scale ranging
from 1 to 6 (1 = normal, 2 = mild disability, 3 = moder-
ate disability, 4 = severe disability, 5 = coma or vegeta-
tive state, and 6 = brain death).
It should be noted that although the JaRPAC regis-
try includes information on patients who died in the
emergency room, we excluded the data of these pa-
tients at the point of data extraction. Furthermore,
we did not exclude any other patients while creating
the prediction model for LSPs. This means that our
analysis included data of patients who died within
several days after ICU admission in SSPs because the
clinicians could not predict whether patients would
die at the point of their ICU admission.
In total, seven facilities registered their patients’
data in the JaRPAC database during our study period.
The characteristic breakdown of these facilities is as
follows: (1) four pediatric ICUs (4–20 beds; a total of
38 beds) and (2) three general (mixed adult-pediatric)
ICUs (12–20 beds; a total of 52 beds). There were no
ICUs classified as “cardiac ICUs.”
We obtained the same JaRPAC data as described above
from the same facilities included in the original dataset
for consecutive patients (< 16 years) from October 2016
to September 2017 to test the accuracy of prediction for
the newly developed score as we shall explain later; these
data represented the “internal” validation dataset. In
addition, we obtained the same data from facilities newly
joined during this period (not included in the original
dataset, one general PICU [10 beds] and one general
adult-mixed ICU [8 beds]); these data represented the
“external” validation dataset.
Defining the LSPs
LOS was calculated by subtracting the date of ICU
admission from the date of ICU discharge plus one.
The definition of LSP was determined considering
various indexes by following the techniques described
in similar studies [19, 20]: (1) beyond five times the
median LOS, (2) beyond the 95th percentile of the
LOS, (3) greater than two standard deviations from
the mean in Gaussian distribution, and (4) beyond
the visually recognized threshold from the “tail” por-
tion of the LOS histogram in the case of skewed
distribution.
Statistical analysis
After we examined the distribution of LOS in ICUs
to define the LSP, we conducted a descriptive analysis
of the participants overall or stratified by the LSP
status. We then compared the risk of mortality (i.e.,
expired) obtained from the discharge disposition as
clinical outcomes between LSPs and SSPs. We also
calculated the rate of mortality considering the pa-
tient-day as a denominator, stratified by the LOS.
We then created a prediction model for LSPs. We
conducted a backward selection stepwise logistic
regression model and used the significance level of
p = 0.05 for removal of variables from the model.
When a least-significant variable was non-significant,
the variable was removed and the model was re-esti-
mated; the final model was developed when all of the
variables were significant. We entered the following
variables in the model in the beginning: age
(dichotomous, < 2 years or ≥ 2 years); emergency ad-
mission (dichotomous); post CPR admission (dichot-
omous); admission due to circulatory disorders
(dichotomous); disease category of myocarditis, con-
genital heart disease, encephalopathy/encephalitis,
liver dysfunction, lung tissue disorders, or multiple
trauma; PIM2 (dichotomous, < 1 or ≥ 1); PCPC score
on admission (dichotomous, < 2 or ≥ 2); or ISS (di-
chotomous, < 10 or ≥ 10). We selected the two reasons
for admission and six disease categories because they pre-
dicted the LSPs based on the descriptive analysis. We then
removed sex and chromosome abnormalities because the
validation dataset did not include these variables. After
selecting variables using a logistic regression model,
we estimated odds ratios (ORs) with 95% confidence
intervals (CIs) for each of the remaining variables and
computed the area under the receiver operating char-
acteristic (ROC) curve (AUC). To increase the useful-
ness of the prediction model, we assigned integer
score points to each remaining variable based on the
ORs and created a prediction rule for the LSPs, that
assigned the defined integer score points based on
the presence of each variable for the patients. We cal-
culated the sum of all points for each patient in the
current dataset, as well as, the validation dataset and
again calculated the AUC. We also calculated the sen-
sitivity and specificity of the prediction rule after de-
fining the certain cutoff value based on the ROC
curve.
Stata SE version 15 (StataCorp, College Station, TX,
USA) was used for all analyses. This study was ap-
proved by the Okayama University Graduate School
of Medicine, Dentistry and Pharmaceutical Sciences
Institutional Review Board (Eki853 and Ken1812-027).
Results
There were 4108 ICU admissions during the 3 year
study period included in the analysis dataset. Of these
admissions, just one case was excluded because the
dates of admission and discharge were obviously
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incorrect. Thereafter, the data for 4107 patients were
used as the final analysis dataset.
LSP definition
Figure 1 portrays the frequency distribution of pa-
tients based on the length of stay in the ICU. The
median and mean LOS were 3.0 (minimum to max-
imum, 1–370) and 6.2 ± 11.7 days, respectively. Con-
sidering its rightward skewed distribution, we
calculated or visually identified three indexes de-
scribed above to decide upon the clinical threshold
for prolonged ICU stays: (1) 15 days for five times the
median LOS, (2) 19 days as the 95th percentile of
LOS, and (3) 13 days as the start of the “tail” of the
distribution shown in Fig 1. Taken together these re-
sults, for the purpose of practical convenience, we de-
fined LSPs as patients who had a LOS in the ICU
greater than 14 days.
Characteristics of the study population on admission
Table 1 shows the patients’ characteristics on admis-
sion. Overall, 42.9% (n = 1762) of patients were less
than 2 years old and the majority of patients had
emergency admissions (55.4%, n = 2277). Postoperative
management was the most common reason for the
ICU admission (44.2%, n = 1814). Most patients had
an endogenous disease (91.6%, n = 3760) and had a
good functional status before ICU admission (76.4%,
n = 3136, PCPC 1 and 2). Chromosomal abnormality
was reported among 6.4% (n = 263) of patients, 59.7%
(n = 157) of whom were 21 trisomy.
LSPs accounted for 8.0% (n = 330) of all patients. The
proportion of LSP patients who were less than 2-years
old was even greater than that of SSPs (60.9% versus
41.3%). The admission reasons of post-CPR and circula-
tory disorders were more common in LSPs. In terms of
diagnosis, those with liver dysfunction, myocarditis/car-
diomyopathy, CHD, encephalitis/encephalopathy, and
lung tissue disease (pneumonia) were more likely to be
LSPs. There was no correlation between PCPC before
admission and LOS.
Clinical outcomes
Table 2 summarizes the clinical outcomes of the
study population. LSPs consumed 38.0% of the ICU
bed days. Mortality was seven times higher in LSPs
than SSPs. Additionally, mortality during the first 0–
14 ICU admission days was 0.0024/patient-days, while
mortality after 14 ICU admission days was 0.0058/pa-
tient-days. Thus, if a patient stayed in the ICU for
more than 14 days, mortality per day would increase
by approximately 2.5 times that of a patient who
stayed in the ICU for 14 days or less. After discharge
from the ICU, most patients were managed in the
same hospital as the ICU.
Predictive model for LSPs on admission
In the first stepwise logistic regression model, all the
remaining variables had ORs more than one as expected
from the descriptive analysis, so we accepted the model.
The AUC was 0.82 and we showed the remaining vari-
ables in Table 3. As liver dysfunction (non-post oper-
ation) and PIM2 (≥ 1) had ORs of more than 5, we
assigned a score of 2 to the variables and a score of 1 to
the other variables. Thus, we ascertained the following
prediction rule for LSPs.
Fig. 1 Distribution of pediatric length of stay in intensive care units. Forty data points (91 patients) are outside the x-axis limits
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After we applied the prediction rule to the patients in
the current dataset, the AUC was 0.79. When we used
the cutoff point of 3 based on the ROC curve, the sensi-
tivity and specificity for the LSPs were 87.0% and 59.4%,
respectively. When we applied the prediction rule to the
“internal” validation dataset (n = 378), the AUC was 0.80
and the sensitivity and specificity of LSPs were 92.6%
and 60.2%, respectively, using the same cutoff point. Fur-
thermore, when we applied the prediction rule to the
“external” validation dataset (n = 295), the AUC was 0.76
and the sensitivity and specificity of LSPs were 91.7%
and 53.9%, respectively, using the same cutoff point.
As the OR of PIM2 (≥ 1) was relatively higher than
that of any other variables, we examined the predict-
ive ability of PIM2 by itself for LSPs. PIM2 and pa-
tients’ LOS had a negligible correlation (r = 0.20,
Additional file 2). Moreover, the AUC was 0.71 when
we applied PIM2 as a prediction rule for LSPs; this
was lower than that of our newly developed predic-
tion rule.
Predictive score ¼ PIM2 ≥1ð Þ  2þ liver dysfunction non−post operationð Þ  2þ post CPR 1
þ circulatory disorder 1
þ liver dysfunction post−operative management of liver transplantationð Þ  1
þ encephalitis=encephalopathy  1þmyocarditis=cardiomyopathy  1þ CHD 1
þ lung tissue disease 1þ PCPC before admission ≥2ð Þ  1þ age < 2 yearsð Þ  1
Table 2 Clinical outcomes of pediatric patients in intensive care units in Japan
All Patients
n = 4107
SSPs
n = 3777
LSPs
n = 330
Length of stay (days)
Average (SD) 6.2 (11.7) 4.2 (2.9) 29.6 (31.8)
Median (IQR) 3.0 (2.0–7.0) 3.0 (2.0–6.0) 21.0 (17.0–31.0)
ICU bed days [numbers (% total)] 25659 15909 (62.0%) 9750 (38.0%)
Mortality [numbers (%)] 79 (1.9%) 49 (1.3%) 30 (9.1%)
Discharge route [numbers (%)]
General ward 3649 (88.8%) 3390 (89.8%) 259 (78.5%)
Transfer to original hospital 116 (2.8%) 90 (2.4%) 26 (7.9%)
Transfer to new hospital 51 (1.2%) 40 (1.1%) 11 (3.3%)
Home 212 (5.2%) 208 (5.5%) 4 (1.2%)
PCPC on discharge [numbers (%)]
1 2572 (62.6%) 2418 (64.0%) 154 (46.7%)
2 426 (10.4%) 395 (10.5%) 31 (9.4%)
3 435 (10.6%) 402 (10.6%) 33 (10.0%)
4 557 (13.6%) 498 (13.2%) 59 (17.9%)
5 32 (0.8%) 14 (0.4%) 18 (5.5%)
6 85 (2.1%) 50 (1.3%) 35 (10.6%)
Delta PCPC* [numbers (%)]
0 3871 (94.3%) 3633 (96.2%) 238 (72.1%)
1 66 (1.6%) 52 (1.4%) 14 (4.2%)
2 48 (1.2%) 29 (0.8%) 19 (5.8%)
3 38 (0.9%) 17 (0.5%) 21 (6.4%)
4 28 (0.7%) 9 (0.2%) 19 (5.8%)
5 48 (1.2%) 29 (0.8%) 19 (5.8%)
Unknown 8 (0.2%) 8 (0.2%) 0 (0)
*PCPC on discharge – PCPC before admission
IQR interquartile range, LSPs long-stay patients, PCPC Pediatric Cerebral Performance Category, SD standard deviation, SSPs short-stay patients
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Discussion
In this study, we have newly provided an overview of
pediatric long-stay ICU patients in Japan using the JaR-
PAC, a nationwide and multicenter database. Addition-
ally, we have provided a unique and simple predictive
scoring system using available data at the point of ICU
admission to prospectively identify pediatric LSP-candi-
dates. We showed that pediatric LSPs have a significant
presence in Japanese ICUs with high rates of bed
utilization and mortality. Eight percent of the entire
population used almost 40% of the bed days. Addition-
ally, the mortality in pediatric LSPs was significantly
higher. These data signify the need for further interven-
tions for improved LSP outcomes. Thus, identifying LSP
candidates on ICU admission will help clinicians to
intervene with such patients in the early course of the
ICU stay. Although there have been multiple studies
which provided prediction models for pediatric LSPs,
our newly developed prediction system is so practical
that clinicians could identify pediatric LSP candidates by
simply adding the scores assigned to the risk factors.
Table 4 provides a summary of previous studies con-
ducted regarding pediatric LSPs in ICUs; a study with a
specific condition (post-cardiac surgery) was excluded.
All studies were based on pediatric ICUs, and most of
them were single-center studies. Even though the defin-
ition of LSPs differed from study to study, in all the
studies, LSPs were commonly described as occupying
excessive ICU bed days (18.5–63%) despite their smaller
population frequencies (1.0–7.3%). Moreover, the
mortality among LSPs was higher than that among
SSPs in all studies. Comparable results were obtained
from our study, although in this study, data from
multiple mixed adult-pediatric ICUs were included.
The differences in outcomes between pediatric ICUs
and mixed adult-pediatric ICUs should be investigated
in further studies.
Table 5 summarizes the predictors of LSP or inde-
pendent LSP-associated factors based on the findings of
previous studies. Our study and previous studies include
similar LSP predictors or LSP-associated factors includ-
ing pneumonia [6] (i.e., lung tissue disease) and the ex-
istence of underlying diseases [5, 6] (e.g., chronic total
parenteral nutrition, tracheostomy, intracranial catheter,
and higher PCPC). Intriguingly, our study showed post-
CPR status as one of the LSP predictors, whereas no
CPR-need prior to admission was identified as an LSP
predictor in an American study [6]. This might have
been caused by the relatively low acceptance of treat-
ment withdrawal in Japan. The mortality in pediatric
ICUs after out-of-hospital cardiac arrest (OHCA) was
reported to be as high as 45–50% in Western countries
[21, 22], whereas this was as low as 34.1% based on our
data, as shown in Additional file 3. Conversely, remark-
ably high rates of poor neurological outcomes at ICU
discharge (PCPC = 4 or 5) in LSPs were seen in our ana-
lysis (Additional file 3). A study from a single center in
the USA showed that 81% of the modes of death after
pediatric OHCA were classified as brain death or with-
drawal due to neurological prognosis after a median ICU
admission of 4 days [22]. Given the fact that the guide-
lines for treatment withdrawal have only recently been
published in Japan [23], it is a stretch to assume that the
choice to withdraw from treatment for pediatric patients
has been widely accepted in daily ICU management in
Japan. However, further validations are required to cor-
roborate this hypothesis.
We also found that LSPs were significantly younger
and were likely to be admitted with an emergency
status including post-CPR or circulatory disorders
when compared with SSPs. Additionally, LSPs were
more likely to have a higher predicted mortality
(PIM2). Thus, it is not surprising that these factors
were reflected as items in our developed predictive
scoring system. In particular, the predictive mortality
rate seemed to have significance for LSP prediction,
which was assigned 2 points in the scoring system.
There may be a reason in the computation method of
predictive mortality using PIM2. PIM2 is calculated
based on multiple indices such as (1) mechanical ven-
tilation at any time during the first hour in the ICU,
(2) emergency admission, (3) admission for recovery
from surgery or a procedure, (4) admission following
cardiac bypass, and (5) cardiac arrest preceding
Table 3 Predictive Score for pediatric long-stay patients
(score≥ 3)
Odds ratio (95% CI) Score
Reasons for admission
Post CPR 4.60 (2.75–7.68) 1
Circulatory disorder 2.11 (1.34–3.31) 1
Disease category
Liver dysfunction
(non-post operation)
9.24 (5.55–15.38) 2
Post-operative management
of liver transplantation
4.31 (2.58–7.20) 1
Myocarditis/cardiomyopathy 3.15 (1.57–6.34) 1
Encephalitis/encephalopathy 3.16 (1.95–5.13) 1
CHD (non-post operation) 2.44 (1.18–5.04) 1
Lung tissue disease (pneumonia) 1.80 (1.15–2.80) 1
Other factors
PIM2 ≥ 1 10.97 (6.62–18.19) 2
Age < 2 years 1.60 (1.23–2.08) 1
PCPC ≥2 before admission 1.36 (1.03–1.79) 1
CHD congenital heart disease, CI confidence interval, CPR cardio-pulmonary
resuscitation, PCPC Pediatric Cerebral Performance Category, PIM2 Pediatric
Index of Mortality 2
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admission. These indicators have been known to be
involved in the patients’ LOS in the ICU [6, 24–26].
Accordingly, PIM2 naturally seems to have been
chosen as a significant predictive factor; however, our
study showed that our newly developed rule per-
formed better than PIM2 by itself to predict LSPs
upon admission. Thus, it could be inferred that our
predictive model was a result of correct weighting of
PIM2 using additional factors listed on Table 3.
Liver dysfunction for non-operative management,
myocarditis/cardiomyopathy, and encephalopathy/en-
cephalitis are the curious indices in our predictive
LSP score. We speculate that these factors have sig-
nificance in LSPs because of their unique treatment
modality features.
1. Liver dysfunction for non-operative management
Acute liver failure in patients who need direct ICU
management (i.e., the primary reason for ICU
admission was not for post-operative management)
could be severe because of fulminant hepatic
failure, thus requiring aggressive blood-purification
[7]. Moreover, a large number of these patients
would require liver transplantation [27], resulting in
a longer ICU stay as shown in Additional file 4.
There are very few brain-dead donor livers available
in Japan; thus, this might contribute to longer
waiting times causing prolonged ICU admissions
[28].
2. Myocarditis/cardiomyopathy
It is well known that there is a wide range of
disease severities in this disease category.
Mechanical circulatory support (MCS) with
extracorporeal membrane oxygenation (ECMO)
among rapidly deteriorating patients can be
imperative for recovery or might act as a bridge to
probable heart transplantation. The number of
myocarditis patients who undergo MCS has been
increasing in Japan [29], placing an additional
demand on ICUs for this population. ECMO use
during PICU stay has been reported as a factor
associated with LSP [5]. A report from a single
Japanese center described that myocarditis patients
underwent ECMO therapy for median 6 days when
Table 4 Summary of the published studies on pediatric long-stay patients
Study Author, year Country Study period No. of ICUs ICU characteristics Study population Exclusion criteria
1 Pollack et al., 1987 [3] USA 1981–2, 1984–5 1 Multidisciplinary
PICUs
647 NA
2 Marcin et al., 2001 [6] USA NA 32 General PICUs 11,165 NA
3 van der Heide et al.,
2004 [10]
Netherlands 1992–1997 1 Multidisciplinary
PICUs
34 Age < 1 year old,
>18 years old
4 Naghib et al., 2010 [7] Netherlands 2003–2005 1 Multidisciplinary
PICUs
2607 None
5 Namachivayam et al.,
2012 [8]
Australia 1989–2008 1 Tertiary PICUs 27,536 NA
6 Nupen et al., 2017 [17] South Africa NA 1 Multidisciplinary
PICUs
1126 NA
7 Pollack et al., 2018 [5] USA 2011–2013 8 General and cardiac
PICUs
10,078 Age > 18 years old
8 Knaup et al., 2019 Japan 2013–2016 7 General PICUs and
mixed adult-pediatric
ICUs
4107 Age > 16 years old
Study LSP definition LSP number LSP age LOS of LSPs (days) Bed occupancy
by LSPs
Mortality (SSPs/LSPs)
1 > 13 days 7.1% (n = 46) 13months* 35.8** 50.0% 7.3%/17.4%
2 > 12 days 4.7% (n = 460) 45.5 months* 28.3* 36.1% 4.4%/15.0%
3 ≥ 30 days NA (n = 19) 10.7 years** 37** NA NA/10.5%
4 ≥ 28 days 4.4% (n = 116) 1 month** 56* 63.0% 4.6%/22.0%
5 ≥ 28 days 1.0% (n = 269) 4.2 months* 40* 18.5% NA
6 > 19 days 4.8% (n = 54) 4.0 months* 29.5* 30.4% 2.4%/29.6%
7 ≥ 19 days 4.6% NA NA 37.6% NA
8 > 14 days 8.0% (n = 330) 10 months* 21* 38.0% 1.3%/9.1%
*Median
**Mean
ICU intensive care unit, LOS length of stay, LSP(s) long-stay patient(s), NA not available, SSPs short-stay patients, USA the United States of America
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ECMO was implemented [30], which is
comparative with the findings in this study
(Additional file 5).
3. Encephalitis/encephalopathy
Encephalitis/encephalopathy should influence LOS
as a result of its neurological impairment with
different ranges as well as the need for treatment
using hypothermia therapy [31–33]. Suggested
hypothermia protocols require approximately 5 days
to complete [32, 33]. One case series from a single
Japanese ICU reported that these patients
underwent mechanical ventilation for 9.4 days on
an average [33]. The use of neuromuscular blockade
for temperature control can also influence LOS [5].
The frequent prevalence of encephalitis/
encephalopathy in East Asia may involve the
statistical significance in our study in Japan [34].
Overall, these unique treatment modalities still need
to be validated for their efficacy, despite their practice in
some ICUs in Japan. Thus, the management of these dis-
eases would be expected to change due to further re-
search developments.
It is intriguing that our LSP predictive score contains
the patients’ status post-liver transplantation. It seems that
their LOS depends on their number of ventilation days
(Additional file 6). A previous study reported that pro-
longed mechanical ventilation in pediatric liver transplant
recipients had longer ICU LOS, which was associated with
younger patient age, preoperative hypocalcemia, and in-
creasing duration of surgery [35]. The addition of this
clinical information might improve the specificity of the
current LSP predictive score in future studies.
The definition for LOS has been an important discus-
sion point for a long time in the research on LSPs. Previ-
ous studies employed different cutoffs ranging from 2 to
30 ICU days. In this study, we attempted to define LSPs
using an acceptable approach for everyone [19] and
employed a cutoff of 14 ICU days. Eventually, the cutoff
point coincided with the maximum number of days that
hospitals are allowed to charge for pediatric ICU man-
agement according to the 2019 Japanese health insur-
ance system. Thus, our cutoff makes the study more
practical for Japanese ICUs.
This study was inherently subject to some other limi-
tations. First, institutional factors, such as the differences
in practice, capacity, or patient populations, could not
be accounted for in our extracted data. These factors
may influence patients’ LOS because the discharge cri-
teria from ICU may vary among facilities. Furthermore,
the decision to discharge a patient may not always be
based on the criteria; sometimes it is influenced by bed-
control matters throughout the hospital or the regional
regulation among related hospitals. Thus, the LOS in
ICUs may not always precisely indicate the patients’ clin-
ical needs. Second, two variables (sex and chromosomal
abnormality) that seemed significant for the prediction
of LSPs were unavailable in our validation dataset due to
the revision of registration templates during our study
period. There might be other factors that were not in-
cluded in the JaRPAC database that could have predicted
a long stay in ICU better. Additionally, the stepwise vari-
able selection we performed in our analysis does not ne-
cessarily assure us of the independence of the variables
selected in the model. However, as expected, all the
remaining variables had ORs of more than one based on
descriptive analysis, suggesting limited concerns regard-
ing multicollinearity. Third, the size of our validation
dataset was relatively small. Additional verification stud-
ies are warranted using external databases or prospect-
ively accumulated datasets in daily ICU settings. Fourth,
descriptive patient factors on ICU admission might be
statistically important but insufficient to predict the LOS
of each patient [5]. Our newly developed LSP predictive
score has high sensitivity with low specificity. As LOS
prediction aims primarily to improve outcomes for pa-
tients and their families, high sensitivity of LSP predic-
tion is required. Conversely, low specificity might hinder
the reduction of medical costs and the utilization of re-
sources. Analysis of the association between patients’
Table 5 Predictors of long-stay pediatric patients or
independent long-stay patient-associated factors
Study* Factors
2 [6] • Age < 12 months
• Previous ICU admission
• Emergency admission
• No CPR before admission
• Pneumonia
• Chronic TPN
• Chronic tracheostomy
• Admission from another ICU
• Other respiratory diseases
• Never discharged from the
hospital
• Ventilator
• Intracranial catheter
• 10 < PRISM III—24 score < 33
6 [17] • Female gender
7 [5] • Age < 12 months
• Moderate or severe
baseline FFS
• PRISM III total score
• ECMO during PICU stay
• RRT during PICU stay
• MV during PICU stay
• Vasoactive infusions during PICU
stay
• Antibiotics during PICU stay
• Neuromuscular blockade during
PICU stay
• Steroids use during PICU stay
8 • Age < 2 years
• Post CPR
• Circulatory disorder
• Myocarditis/
cardiomyopathy
• PCPC ≥ 2 before
admission
• Encephalitis/encephalopathy
• Liver dysfunction**
• CHD (non-post-operative)
• Lung tissue disease (pneumonia)
• PIM2 ≥ 1
*Study numbers are consistent with those in Table 4
**Status for non-post operation or post-liver transplantation
CHD congenital heart disease, CPR cardiopulmonary resuscitation, ECMO
extracorporeal membrane oxygenation, FFS Functional Status Scale, ISS Injury
Severity Score, MV mechanical ventilation, PCPC Pediatric Cerebral
Performance Category, (P)ICU (pediatric) intensive care unit, PIM2 Pediatric
Index of Mortality 2, PRISM Pediatric Risk of Mortality, RRT Renal replacement
therapy, TPN total parenteral nutrition
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outcomes and medical costs or resource consumption in
LSPs is warranted in future studies. Fifth, the JaRPAC’s
disease categories are registered based on the primary
target disease upon admission, which suggest that our
analysis might overlook the accompanied conditions
(e.g., shock [circulatory disorder] with encephalitis/en-
cephalopathy). Therefore, these viewpoints should be in-
cluded in future verification studies. Additionally,
technological and scientific innovations in ICU treat-
ment could shorten the LOS. Thus, regular revisions
would be necessary to accurately reflect the pediatric
LSP population.
Conclusions
Despite being a demographic minority, pediatric LSPs had
high rates of bed utilization and mortality in Japanese
ICUs. Our newly developed predictive scoring system may
help to identify pediatric LSPs upon admission.
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